Listed by the USPTO as ALEMAN, SARAH WEBB
Tech Center 3700 • Art Units: 3731 3771 3774 3783
This examiner grants 62% of resolved cases
ALEMAN, SARAH WEBB handles cases in tech center 3700 and art unit 3731. The profile records 600 resolved cases and an allowance rate of 62.2%. Median time to allowance is 1336 days. Interviews are associated with a 23.6% lift in the allowance rate, making interviews a relevant consideration when counsel develops a prosecution plan for this examiner.
The listed companies are Boston Scientific Corporation, Cook Medical Technologies LLC, and Mirus LLC. The listed firms are SEAGER, TUFTE & WICKHEM, LLP, MacMillan, Sobanksi & Todd, LLC - Cook Medical, and Boston & Galway. This reported activity provides context for matters in art unit 3731.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19574544 | GUIDE FLEX SYSTEM FOR DELIVERY HANDLE FOR PROSTHETIC VALVE DELIVERY SYSTEMS | Non-Final OA | MiRus LLC |
| 18231348 | PERIPROSTHETIC SHOULDER FRACTURE REPAIR | Final Rejection | Stryker European Operations Limited |
| 18599811 | STENT DELIVERY DEVICE WITH SECONDARY VISUAL INDICATOR TO ENSURE PROPER POSITIONING TO SEE PRIMARY VISUAL INDICATOR | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18096600 | SYSTEMS AND METHODS FOR RESHAPING A HEART VALVE | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18096591 | SYSTEMS AND METHODS FOR RESHAPING A HEART VALVE | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 17482060 | STENT HAVING A TACKY SILICONE COATING TO PREVENT STENT MIGRATION | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 17351868 | Prosthetic Heart Valve Having an Improved Tubular Seal | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18551349 | INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING | Final Rejection | The General Hospital Corporation |
| 19303343 | METHOD AND APPARATUS FOR ANTEGRADE TRANSCATHETER VALVE REPAIR OR IMPLANTATION | Final Rejection | Vantis Vascular, Inc. |
| 18034443 | MULTIAXIAL ARTIFICIAL MUSCLE TISSUE, AND METHOD AND STRUCTURE FOR FORMING SAME | Non-Final OA | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18778973 | INTRAOCULAR LENS INJECTOR | Non-Final OA | Hoya Corporation |
| 17689475 | ENDOVASCULAR PRESSURE GRADIENT DETERMINATION METHOD | Final Rejection | Medtronic Vascular, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.2% of resolved applications examined by Sarah Webb Aleman were allowed (600 resolved cases), compared with 63.1% across Art Unit 3731 over the last five years.
This examiner's interview lift is +23.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sarah Webb Aleman took 1,336 days on average from filing to allowance.
Sarah Webb Aleman examines applications in Art Unit 3731 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
